These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 26712133)
1. Emergence of colistin-resistant bacteria in humans without colistin usage: a new worry and cause for vigilance. Olaitan AO; Morand S; Rolain JM Int J Antimicrob Agents; 2016 Jan; 47(1):1-3. PubMed ID: 26712133 [TBL] [Abstract][Full Text] [Related]
2. Colonization and infection by colistin-resistant Gram-negative bacteria in a cohort of critically ill patients. Kontopidou F; Plachouras D; Papadomichelakis E; Koukos G; Galani I; Poulakou G; Dimopoulos G; Antoniadou A; Armaganidis A; Giamarellou H Clin Microbiol Infect; 2011 Nov; 17(11):E9-E11. PubMed ID: 21939468 [TBL] [Abstract][Full Text] [Related]
3. How should we respond to the emergence of plasmid-mediated colistin resistance in humans and animals? Al-Tawfiq JA; Laxminarayan R; Mendelson M Int J Infect Dis; 2017 Jan; 54():77-84. PubMed ID: 27915108 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of faecal carriage of colistin-resistant Gram-negative rods in a university hospital in western France, 2016. Saly M; Jayol A; Poirel L; Megraud F; Nordmann P; Dubois V J Med Microbiol; 2017 Jun; 66(6):842-843. PubMed ID: 28598315 [TBL] [Abstract][Full Text] [Related]
6. Monitoring Colistin Resistance in Food Animals, An Urgent Threat. Liu Y; Liu JH Expert Rev Anti Infect Ther; 2018 Jun; 16(6):443-446. PubMed ID: 29865881 [No Abstract] [Full Text] [Related]
7. Colistin, mechanisms and prevalence of resistance. Bialvaei AZ; Samadi Kafil H Curr Med Res Opin; 2015 Apr; 31(4):707-21. PubMed ID: 25697677 [TBL] [Abstract][Full Text] [Related]
8. Epidemiology of infections caused by polymyxin-resistant pathogens. Giamarellou H Int J Antimicrob Agents; 2016 Dec; 48(6):614-621. PubMed ID: 27865627 [TBL] [Abstract][Full Text] [Related]
9. In vitro activity of colistin against multidrug-resistant gram-negative bacteria isolated at a major army hospital during the military campaigns in Iraq and Afghanistan. Paolino K; Erwin D; Padharia V; Carrero H; Giron L; Burgess R; Burger C; Martinez M; Arrieta P; Wortmann G; Zapor M Clin Infect Dis; 2007 Jul; 45(1):140-1. PubMed ID: 17554723 [No Abstract] [Full Text] [Related]
10. Surveillance cultures for detection of rectal and lower respiratory tract carriage of colistin-resistant Gram-negative bacilli in intensive care unit patients: comparison of direct plating and pre-enrichment step. Germ J; Cerar Kišek T; Kokošar Ulčar B; Lejko Zupanc T; Mrvič T; Kerin Povšič M; Seme K; Pirs M J Med Microbiol; 2019 Sep; 68(9):1269-1278. PubMed ID: 31237536 [No Abstract] [Full Text] [Related]
11. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Li J; Nation RL; Milne RW; Turnidge JD; Coulthard K Int J Antimicrob Agents; 2005 Jan; 25(1):11-25. PubMed ID: 15620821 [TBL] [Abstract][Full Text] [Related]
12. Multidrug-resistant Gram-negative bacteria: how to treat and for how long. Giamarellou H Int J Antimicrob Agents; 2010 Dec; 36 Suppl 2():S50-4. PubMed ID: 21129924 [TBL] [Abstract][Full Text] [Related]
13. Emerging plasmid-encoded colistin resistance: the animal world as the culprit? Poirel L; Nordmann P J Antimicrob Chemother; 2016 Aug; 71(8):2326-7. PubMed ID: 27029849 [No Abstract] [Full Text] [Related]
14. Evolution of β-lactams resistance in Gram-negative bacteria in Tunisia. Chouchani C; Marrakchi R; El Salabi A Crit Rev Microbiol; 2011 Aug; 37(3):167-77. PubMed ID: 21438848 [TBL] [Abstract][Full Text] [Related]
15. Emerging Gram negative resistance to last-line antimicrobial agents fosfomycin, colistin and ceftazidime-avibactam - epidemiology, laboratory detection and treatment implications. Sherry N; Howden B Expert Rev Anti Infect Ther; 2018 Apr; 16(4):289-306. PubMed ID: 29543500 [TBL] [Abstract][Full Text] [Related]
16. In vitro antimicrobial activity of "last-resort" antibiotics against unusual nonfermenting Gram-negative bacilli clinical isolates. Jacquier H; Le Monnier A; Carbonnelle E; Corvec S; Illiaquer M; Bille E; Zahar JR; Jauréguy F; Fihman V; Tankovic J; Cattoir V; Microb Drug Resist; 2012 Aug; 18(4):396-401. PubMed ID: 22335615 [TBL] [Abstract][Full Text] [Related]
17. Multidrug-resistant Gram-negative infections: the use of colistin. Michalopoulos AS; Karatza DC Expert Rev Anti Infect Ther; 2010 Sep; 8(9):1009-17. PubMed ID: 20818945 [TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of polymyxin resistance: knowns and unknowns. Baron S; Hadjadj L; Rolain JM; Olaitan AO Int J Antimicrob Agents; 2016 Dec; 48(6):583-591. PubMed ID: 27524102 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic evaluation of colistin sodium. Michalopoulos AS; Karatza DC; Gregorakos L Expert Opin Drug Metab Toxicol; 2011 Feb; 7(2):245-55. PubMed ID: 21128824 [TBL] [Abstract][Full Text] [Related]
20. Capillary electrophoresis for fast detection of heterogeneous population in colistin-resistant Gram-negative bacteria. Sautrey G; Duval RE; Chevalley A; Fontanay S; Clarot I Electrophoresis; 2015 Oct; 36(20):2630-3. PubMed ID: 26101140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]